PHI challenged by ‘operational issues’
by Wally Northway
Published: March 29,2010
MADISON — Phosphate Holdings Inc. (PHI), for the fourth quarter, recorded a net loss of $2.8 million, or $0.36 per share, compared to a loss of $58.1 million, or $7.59 per share, during the same period the prior year.
For the year, PHI reports a net loss of $13.6 million, or $1.76 per share, compared to a net loss of $3.5 million, or $0.46 per share, the previous year. The company said its year-to-date results were materially impacted by inventory write-downs to net realizable value of approximately $10.4 million.
Net sales for the fourth quarter were $47.2 million, compared to $35.8 million during the same period last year. For the year, net sales were $186.3 million, a 58 percent decrease from the prior year.
The fertilizer-maker says it has been plagued by operational issues during the fourth quarter of last year and into the first quarter of 2010. Production shortfalls are being blamed on unplanned outages in its sulfuric acid operations.
Various factors, including extreme cold temperatures and heavy rains, negatively impacted operations during the first quarter of 2010. In addition, subsequent to the turnaround of PHI’s No. 2 sulfuric acid plant, problems with the coolers in the inter-stage absorption towers have developed, and the company is working to replace the coolers.
To sign up for Mississippi Business Daily Updates, click here.
Twang & Tourism: The Country Music Trail
Still planning that summer vacation?
FOLLOW THE MBJ ON TWITTERMy Tweets
Top Posts & Pages
- Education officials changing school rating system
- Gulf LNG terminal mulling export opportunities
- Historic COFO building demolished due to structural problems
- Capital City voters to elect new mayor in runoff
- Study: Mississippi has highest sales tax rate in U.S.
- New shareholders named for Copeland, Cook, Taylor and Bush
- MSU's Gilbert named finalist for Austin Peay presidency
- Communities vie for TVA sustainability designation
- American HealthTech passes Medicare tests
- First Corolla earmarked for export rolls off of Toyota's line